Get Healthy!

"Listen, I'm not a Pollyanna,"New Yorker David Cabelis makes clear. "I'm a cab driver."

"But I was diagnosed with this cancer,"the 72-year old said. "Bladder cancer, that's what I had, and then I had this treatment, and it was the most amazing experience. And thank God, now I'm clean, I'm cancer-free. So, if you're asking me about this treatment, I'll tell you one thing: I'm not objective...

It's common knowledge that loss is a part of male aging -- loss of hair, loss of muscle tone, loss of vision or hearing.

But men growing older also start losing the very thing that makes them biological males, their Y chromosome, and that can leave them more vulnerable to cancer, a new study says.

The loss of the Y chromosome can help cancer cells evade detection by the body's immun...

For years, doctors have thought that a more extensive surgery that removes a wider swath of lymph nodes was the best option for certain patients with bladder cancer. Now, a new clinical trial is upending that belief.

Researchers found that the strategy -- known as extended lymphadenectomy -- was no better than standard surgery at prolonging patients' lives or the amount of time they live...

Patients with a high-risk bladder cancer now have a new option to treat it.

The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what's called high-risk non-muscle-invasive bladder cancer (NMIBC) that hasn't responded to the standard treatment, Bacillus Calmette-Guérin (BCG), but hasn't spread. BCG i...

The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there's been little change in the number of new cancer cases.

"From 2015 to 2019, overall cancer death rates decreased by 2.1% per year in men and women combined," according to a statement issued by the NCI on Thursday.

The biggest d...

Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year.

Bradshaw talked about his health while co-hosting Fox NFL Sunday.

"Last week on th...

Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return, a new clinical trial finds.

Among 700 patients with urothelial cancer of the bladder or other parts of urinary tract that had spread to musc...

The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.

The study, of more than 700 cancer facilities nationwide, found that in January 2021 - a year after COVID's emergence in the United States - most still had not recovered their pre-pandemic s...

New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients' risk for poor outcomes.

For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical facilities.

Procedures to diagnose cancer were used less often and there were fewer new cancer diagnoses in 2020 t...

Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.

Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State College of Medicine study.

"The public often hears that the U.S. spends an inordinate amount of money on health car...